12-06-2025

New price list for reimbursed medicines: more medicines, lower prices

From 1 July this year, a new price list for reimbursable medicines will come into force, with a record number of added medicines, more groups of medicines and lower base medicine prices. These changes are expected to save the Compulsory Health Insurance Fund (CHIF) around EUR 5.7 million in the second half of the year.

“We are pleased that the list of reimbursable medicines, which will come into force on 1 July this year, contains a record number of medicines, as many as 2 160 items. We are also pleased with the increasing number of medicine groups, which means better treatment options for patients. This price list is a consistent step forward in the implementation of one of the objectives of the Government’s programme - to improve the accessibility of essential and innovative reimbursable medicines to patients”, says Anželika Oraitė, Director of the Pharmaceutical Department of the Ministry of Health.

The new price list includes 2,160 medicines, including 236 parallel import medicines and 132 nominal medicines. Compared to the first half of this year, the number of medicines has increased by 126 and the number of groups of medicines has increased from 868 to 889. The number of parallel imported medicines in the half-year price list also increased significantly from 198 to 236.

It should be noted that as many as 582 medicines had their base price reduced and 377 medicines received additional discounts from suppliers. Such decisions make it possible to ensure greater access to medicines for patients, especially those who need to take medicines regularly.

“We want patients to receive effective and safe medicines at affordable prices. Adding more medicines to the price list, especially generics and parallel imports, increases competition between suppliers, which helps to reduce the prices of medicines and save money,” says Evaldas Stropus, Head of the Pharmaceuticals Reimbursement Division of the National Health Insurance Fund.

Preliminary estimates suggest that the CHIF budget will save around EUR 5.7 million in the second half of this year. The savings will be used to add new medicines or to expand the conditions for prescribing medicines that are already reimbursed. 

Ministry of Health Communication Division

The NHIF invites you: